Search results
US FDA staff raise no major concerns about Eli Lilly Alzheimer's drug By Reuters
Investing.com· 4 hours agoThe drug is a potential rival to Eisai and Biogen (NASDAQ:BIIB)'s Leqembi, which won approval last July. Both treatments are antibodies designed to remove ...
US FDA Panel to Vote on Data, Safety Profile of Lilly Alzheimer's Drug
US News & World Report· 4 hours agodonanemab, a potential rival to Eisai and Biogen's Leqembi, and make recommendations to the FDA. Both the drugs are antibodies designed to remove toxic beta amyloid plaques from the brains of ...
Breakthrough Reveals New Treatment Target For Alzheimer’s
Forbes· 1 day agoDespite being the most prevalent neurodegenerative disease globally, Alzheimer’s has been...
Study Identifies Genetic Variant as a Clear Cause of Alzheimer's—Does This Mean You Should Get...
Health via Yahoo News· 1 day agoNew research suggests that having two copies of a gene variant could be an underlying cause—not just...
Can Alzheimer’s really be reversed, as a new documentary claims?
The Conversation· 13 hours agoTwo people diagnosed with Alzheimer’s claim to have conquered the disease through simple lifestyle changes. Dementia and Alzheimer’< ...
Alzheimer's: Could a new approach halt or slow down progression?
Medical News Today· 4 days agoAbout 32 million people globally have Alzheimer’s disease. Researchers continue to look for a way to...
Grand Rapids hospital offering new treatment for Alzheimer's Disease
WZZM 13 Grand Rapids· 2 days agoTrinity Health Grand Rapids says it's the first in West Michigan to offer a lecanemab, a treatment...
DHR Health in Edinburg administers treatment for early onset Alzheimer's
KRGV Rio Grande Valley· 23 hours agoThe hospital is now the first facility south of San Antonio to successfully administer a new type of...
“Mind-Boggling” – Scripps Scientists Uncover New Molecular Drivers of Alzheimer’s
SciTechDaily· 7 days agoResearchers have identified new potential drug targets for neurodegenerative diseases by taking...
High Confidence AD Drug Donanemab Will Get FDA Panel Nod
Medscape· 3 days agoThe Peripheral and Central Nervous System Drugs Advisory Committee of the US Food and Drug...